The asymmetric Favorskii rearrangement: A synthesis of optically active α-alkyl amides from aldehydes and (-)-1-chloroalkyl p-tolyl sulfoxide

DOI: 10.1016/S0040-4039(00)74098-6

Source and publish data:

Tetrahedron Letters p. 4823 - 4826 (1993)

Update date:2022-08-05

Topics:

Authors:

Satoh Satoh

Motohashi

Kimura Kimura

Tokutake

Yamakawa

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4039(00)74098-6

The first asymmetric Favorskii rearrangement is described. Optically active α-alkyl amides of enantiomeric excess up to 94% were realized from aldehydes and optically active (-)-1-chloroalkyl p-tolyl sulfoxides via the Favorskii rearrangement of optically

Full text of DOI:10.1016/S0040-4039(00)74098-6

Products guided by the article

Product name:(R)-2-Chloro-1-phenyl-2-(toluene-4-sulfonyl)-pentan-3-one

Cas No:152994-54-2

R&D Labs maybe for 152994-54-2

Nanjing Norris Pharm Technology Co., Ltd.

Contact:+86-13901585132

Address:2 Qiande Road, Jiangning sciencepark Hi-Tech Zone, Nanjing, P.R.China
Global United Biotechnology Inc.

Contact:+86-21-61618568

Address:Room 309, Building 6, NO.135, Jinyu Road, Pudong
Nanjing Chemical Material Corp.(NCMC)

website:http://www.njchemm.com

Contact:0086-25-83172879

Address:B12 Technology and Innovation Building, Nanjing Tech University, No.5 New Model Road
Oren Hydrocarbons (Qingdao) Co., Ltd.

Contact:+86-532-68607667-801

Address:Room 3 # 302, No.9 Qingyun Road, Qingdao, China
Shandong Hongxiang Zinc Co., Ltd

Contact:086-0311-66187879

Address:DaWang developing zone

Relevant to this article

The synthesis and biological characteristics of new orally active cephems

Doi:10.7164/antibiotics.46.1897
(1993)
Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S₂ pocket

Doi:10.1016/S0960-894X(98)00729-X
(1999)
Oxidative Verknuepfung von Phosphinomethanidliganden and Titanocen- und Bismutzentren: selektive C-C-, P-C- und P-P-Bindungsbildung

Doi:10.1016/0022-328X(93)86060-U
(1993)
α-Aryl pyrrolidine sulfonamides as TRPA1 antagonists

Doi:10.1016/j.bmcl.2015.11.088
(2016)
Discovery of (10 R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17- tetrahydro- 2H -8,4-(metheno)pyrazolo[4,3- h ][2,5,11]- benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations

Doi:10.1021/jm500261q
(2014)
Reactivity of heterocyclic α-aminomethylsilanes with alcohols

Doi:10.1007/s10593-021-02910-w
(2021)

Article Doi